Skip to main content
Livermore
Livermore
ZHEN

TRV GP II, LLC

SEC CIK
0001614073
Latest filing
Nov 3, 2022

Holdings in Q1 2021

Holdings as of Mar 31, 2021, filed May 12, 2021. Long positions only.

Institution overview
Positions
3
No 13F data for Q4 2020
Portfolio value
$158.2M
No 13F data for Q4 2020
Filed
May 12, 2021
SEC

Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.

Holdings of TRV GP II, LLC in Q1 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
RVMDRevolution Medicines, Inc.COM1,909,317$87.6M55.4%––History
JNCEJounce Therapeutics, Inc.COM6,500,349$66.8M42.2%––History
ALNAAllena Pharmaceuticals, Inc.COM2,790,964$3.88M2.5%––History